Cargando…

The Treatment of Advanced Breast Cancer by Hormone Therapy

Detalles Bibliográficos
Autor principal:	Douglas, Mary
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1952
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2007823/ https://www.ncbi.nlm.nih.gov/pubmed/14925266

Ejemplares similares

Combination Therapies in Advanced, Hormone Receptor–Positive Breast Cancer
por: Olson, Emily
Publicado: (2018)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
por: Sammons, Sarah, et al.
Publicado: (2018)

Prognostic value of peripheral lymphocyte count in hormone therapy of advanced breast cancer.
por: Franks, C. R., et al.
Publicado: (1976)

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer
por: Kirkby, Melanie, et al.
Publicado: (2023)

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
por: Pompei, Luciano de Melo, et al.
Publicado: (2020)

Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer
por: Park, Jeenah, et al.
Publicado: (2018)

3365 Treatment Interruptions and Early Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients
por: Mao, Daqin, et al.
Publicado: (2019)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
por: Iaffaioli, R V, et al.
Publicado: (2005)

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
por: Ditsch, Nina, et al.
Publicado: (2019)

Recent advances in neoadjuvant therapy for breast cancer
por: Potter, David A, et al.
Publicado: (2021)

Menopausal hormone therapy after breast cancer
por: Colditz, Graham A
Publicado: (2005)

Impact of microbiota on breast cancer hormone therapy
por: Terrisse, Safae, et al.
Publicado: (2023)

Switching of Hormone Therapies in Breast Cancer Women
por: Medeiros, Luana Moreira de, et al.
Publicado: (2021)

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
por: Eisen, Andrea, et al.
Publicado: (2008)

Photobiomodulation Therapy in the Treatment of Chronic Dysphagia Post Hormonal Therapy in a Breast Cancer Patient
por: El Mobadder, Marwan, et al.
Publicado: (2019)

Hormonal Therapy and Risk of Breast Cancer in Mexican Women
por: Amadou, Amina, et al.
Publicado: (2013)

Adherence to hormone therapy among women with breast cancer
por: Brito, Claudia, et al.
Publicado: (2014)

Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
por: Ibrahim, Amel B., et al.
Publicado: (2019)

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer
por: Lv, Huimin, et al.
Publicado: (2021)

Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Shen, Le-Sang, et al.
Publicado: (2020)

The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.
por: Williams, G., et al.
Publicado: (1988)

Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?
por: Barnes, D. M., et al.
Publicado: (1979)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Postmenopausal Hormone Therapy and Its Association with Breast Cancer
por: Syal, Arshi, et al.
Publicado: (2020)

Breast cancer survivals and hormone therapy: estrogen and melatonin
por: Soares, José Maria, et al.
Publicado: (2023)

Breast Cancer Hormone Therapy Modulates Breast Implant Capsular Contracture
por: Chawla, Mehak, et al.
Publicado: (2023)

The Development of Schematics to Illustrate Women’s Experiences with Adjuvant Hormone Therapy in the Treatment of Breast Cancer
por: AlOmeir, Othman, et al.
Publicado: (2022)

Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers
por: Ulm, Michael, et al.
Publicado: (2019)

Advancements in the treatment of metastatic hormone-sensitive prostate cancer
por: Li, Hengping, et al.
Publicado: (2022)

Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin
por: Delort, Laetitia, et al.
Publicado: (2019)

Considerations for payers in managing hormone receptor-positive advanced breast cancer
por: Chitre, Mona, et al.
Publicado: (2014)

Treating Elderly Patients With Hormone Receptor–Positive Advanced Breast Cancer
por: Riseberg, David
Publicado: (2015)

Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
por: Mori, Ryutaro, et al.
Publicado: (2014)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
por: Kümler, Iben, et al.
Publicado: (2016)

Factors associated to persistence with hormonal therapy in women with breast cancer
por: Brito, Cláudia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bme2c090q1kcsio7tqvnni9kad